BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for Screen-Cyte 3 %, Medion Diagnostics

2011.03.30

Product group In-vitro diagnostics
Reference 00950/11

Corrective action of Medion Diagnostics for Screen-Cyte 3 % (Lot-No. 601011001) due to hemolysis. Customers were advized to stop the use of the product.

Corrective action for Screen-Cyte 3 %, Medion Diagnostics , Download_VeroeffentlichtAm_EN PDF, 303KB, File does not meet accessibility standards